Vagal afferent stimulation as a cardioprotective strategy? Introducing the concept

Annals of Noninvasive Electrocardiology

Volumn 10, Issue 4, 2005, Pages 441-446

  Fallen, Ernest L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Central processing; Heart rate variability; Phasic modulation of sinoatrial function; Vagal afferent stimulation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANGINA PECTORIS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR DISEASE; CAROTID SINUS; CENTRAL NERVOUS SYSTEM; CORONARY ARTERY DISEASE; ELECTROSTIMULATION; HEART INFARCTION; HEART PROTECTION; HEART RATE; HEART RATE VARIABILITY; HUMAN; IMPLANTATION; INNERVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SPINAL CORD; SYMPATHETIC NERVE; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION; BIOLOGICAL MODEL; CLINICAL TRIAL; ELECTROSTIMULATION THERAPY; HEART; HEART MUSCLE ISCHEMIA; METHODOLOGY; PATHOPHYSIOLOGY;

AFFERENT PATHWAYS; CLINICAL TRIALS; ELECTRIC STIMULATION THERAPY; HEART; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; VAGUS NERVE;

EID: 33644813294     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2005.00065.x     Document Type: Review

References (51)

1. Cannon WB. The Wisdom of the Body. New York, WW Norton, 1932.
2. Malliani A. Homeostasis and instability: The hypothesis of tonic interaction in the cardiovascular regulation of negative and positive feedback mechanisms. In: Lown B Malliani A Prosdocimi M eds. Neural Mechanisms and Cardiovascular Disease. Berlin, Springer-Verlag, 1986.
3. DiCarlo SE Bishop VS. Central baroreflex resetting as a means of increasing and decreasing sympathetic outflow and arterial pressure. Ann NY Acad Sci 2001 940 : 324 337.
4. Spyer KM. The central nervous organisation of reflex circulatory control. In: Loewy AD Spyer KM ( eds. Central Regulations of Autonomic Functions. New York, Oxford, Oxford University Press, 1990, pp. 168 188.
5. Malliani A Lombardi F Pagani M, et al. Spinal cardiovascular reflexes. Brain Res 1975 87 : 239 246.
6. Arora RC Hirsch GM Johnson Hirsch K, et al. Function of human intrinsic cardiac neurons in situ. Am J Physiol 2001 280 : R1736 R1740.
7. Mifflin SW Spyer KM Withington-Wray DJ. Baroreceptor inputs to the nucleus tractus solitarius in the cat: Post-synaptic actions and the influence of respiration. J Physiol (London) 1988 399 : 349 367.
8. Ciriello J Hochstenbach SL Roder S. Central projections of baroreceptor afferent fibers in the rat. In: Robin I Barraco A ( eds. Nucleus of Solitary Tract. London, CRC Press, pp. 1994, 35 50.
9. Sved AF Ito S Madden CJ, et al. Excitatory inputs to the RVLM in the context of the baroreceptor reflex. Ann NY Acad Sci 2001 940 : 247 258.
10. Zhang W Mifflin SW. Excitatory amino acid receptors contribute to carotid sinus and vagus nerve evoked excitation of neurons in the nucleus of the tractus solitarius. J Auton Nerv Syst 1995 55 : 50 56.
11. Spyer KM. Central nervous mechanisms contributing to cardiovascular control. J Physiol 1994 474 : 1 19.
12. von Bezold A Hirt L. Uber die physiologischen Wirkungen des essigsauren Veratrine. Unters Physiol Lab Wurzburg 1867 1 : 73 122.
13. Thoren P. Role of cardiac vagal C fibers in cardiovascular control. Rev Physiol Biochem 1979 86 : 1 95.
14. Bishop VS Peterson DF. The circulatory influence of vagal afferents at rest and during coronary occlusion in the conscious dog. Circ Res 1978 43 : 840 846.
15. Somers VK Mark AL Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 1991 87 : 1953 1957.
16. Heymans C Neil E. Reflexogenic Areas of the Cardiovascular System. London, J&A Churchill, 1958.
17. Ren K Randich A Gebhart GF. Electrical stimulation of cervical vagal afferents. 1. Central relays for modulation of spinal nociceptive transmission. J Neurophysiol 1990 64 : 1098 1114.
18. Ammons WS Blair RW Foreman RD. Vagal afferent inhibition of primate thoracic spinothalamic neurons. J Neurophysiol 1983 50 : 926 940.
19. Eckberg DL. The human respiratory gate. J. Physiol 2003 548 : 339 352.
20. Katona PG Jih F. Respiratory sinus arrhythmia: Noninvasive measure of parasympathetic control. J Appl Physiol 1975 39 : 801 805.
21. Koepchen HP Abel HH Klussendorf D, et al. Respiratory and cardiovascular rhythmicity. In: von Euler C Langergrantz H ( eds. Neurobiology of the Control of Breathing. New York, Raven Press, 1986, pp. 303 312.
22. Barman SM Gebber GL. Basis for synchronization of sympathetic and phrenic nerve discharges. Am J Physiol 1976 231 : 1601 1607.
23. Akselrod S Gordon D Hubel FA, et al. Power spectral analysis of heart rate fluctuations: A quantitative probe of beat to beat cardiovascular control. Science 1981 213 : 220 222.
24. Kamath MV Fallen EL. Power spectrum analysis of heart rate variability: A noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng 1993 21 : 245 311.
25. Pagani M Lombardi F Guzzetti S, et al. Power spectrum analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986 59 : 178 193.
26. Loewy AD. Central autonomic pathways. In: Loewy AD Spyer KM ( eds. Central Regulation of Autonomic Function. New York, Oxford University Press, 1990, pp. 88 103.
27. Kollai M Mizsei G. Respiratory sinus arrhythmia is a limited measure of cardiac parasympathetic control in man. J Physiol 1990 424 : 329 332.
28. Green JH Heffron PF. Observations on the origin and genesis of a rapid sympathetic rhythm. Arch Int Pharmocodyn 1967 169 : 403 411.
29. Koizumi K Terui N Kollai M. Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. J Auton Nerv Syst 1985 12 : 251 259.
30. Ammons WS Blair RW Goreman RD. Vagal afferent inhibition of spinothalamic cell responses to sympathetic afferents and bradykinin in the monkey. Circ Res 1983 53 : 603 612.
31. Bailey JR Fitzgerald DM Applegate RJ. Effects of constant cardiac autonomic nerve stimulation on heart rate variability. Am J Physiol 1996 270 : H2081 H2087.
32. Hedman A Hartikainen J Hakumaki M. Physiologic background underlying short term heart rate variability. Ann Noninv Electrocard 1998 3 : 267 280.
33. Hedman AE Hartikainen JEK Tahvanainen KUO. The high frequency component of heart rate variability reflects cardiac parasympathetic modulation rather than parasympathetic 'tone'. Acta Physiol Scand 1995 155 : 267 273.
34. Schwartz PJ Verrier RL Lown B. Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. Circ Res 1977 40 : 536 540.
35. Vanoli E De Ferrari GM Stramba-Badiale M, et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991 68 : 1471 1481.
36. Randich A Maixner W. Interactions between cardiovascular and pain regulatory systems. Neurosci Behav Rev 1984 8 : 343 367.
37. Feliciano L Henning RJ. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardiovasc Res 1998 40 : 45 55.
38. Lown B Verrier RL. Neural activity and ventricular fibrillation. N Eng J Med 1976 294 : 1165.
39. Kleiger RE Miller JP Bigger JT Jr., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987 59 : 256.
40. Olsson G Wikstrand J Warnold I, et al. Metoprolol induced reduction on postinfarction mortality: Pooled results from five double blind randomized trials. Eur Heart J 1992 13 : 28 32.
41. Cook JR Bigger JT Kleiger RE, et al. Effect of atenolol and diltaizem on heart period variability. J Am Coll Cardiol 1991 17 : 480 484.
42. Braunwald E Epstein SE Glick G, et al. Relief of angina pectoris by electrical stimulation of the carotid sinus nerve. New Eng J Med 1967 227 : 1278.
43. Mannheimer C Eliasson T Andersson B, et al. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. Br Med J 1993 307 : 477 480.
44. Venkatesh G Fallen EL Kamath MV, et al. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure. Heart 1996 76 : 137 143.
45. Casadei B Pipilis A Sessa F, et al. Low doses of scoplomaine increase cardiac vagal tone in the acute phase of myocardial infarction. Circulation 1993 88 : 353 357.
46. The Digitalis Investigation Group. The effect of Digoxin on mortality and morbidity in patients with heart failure. New Eng J Med 1997 336 : 525 533.
47. Kamath MV Upton ARM Talalla A, et al. Neurocardiac responses to vagoafferent electrostimulation in humans. Pacing Clin Electrophysiol 1992 15 : 1581 1587.
48. Kamath MV Upton ARM Tallala A, et al. Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man. Pacing Clin Electrophysiol 1992 15 : 235 243.
49. Tougas G Kamath M Watteel G, et al. Modulation of neurocardiac function by esophageal stimulation in humans. Clin Sci 1997 92 : 167 174.
50. Bajwa A Hollerbach S Kamath MV, et al. Neurocardiac responses to esophageal electric stimulation in humans: Effects of varying stimulation frequencies. Am J Physiol 1997 272 : R896 R901.
51. Kamath MV Hollerbach S Bajwa A, et al. Neurocardiac and cerebral responses evoked by esophageal vagoafferent stimulation in humans: Effect of varying intensities. Cardiovasc Res 1998 40 : 591 599.